New drug combo targets tough cancers in early trial
NCT ID NCT07241039
First seen Nov 21, 2025 · Last updated May 20, 2026 · Updated 21 times
Summary
This early-phase study tests an experimental drug called ABBV-711, given alone or with another drug (budigalimab), in adults with advanced squamous tumors (like certain lung or head and neck cancers) that have stopped responding to standard treatments. The main goals are to check safety and see if the drugs shrink tumors. About 220 participants will take pills or receive infusions at clinics worldwide over up to 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SQUAMOUS TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Carolina BioOncology Institute /ID# 272380
RECRUITINGHuntersville, North Carolina, 28078, United States
-
City Of Hope Comprehensive Cancer Center /ID# 276550
RECRUITINGDuarte, California, 91030, United States
-
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278432
RECRUITINGIrvine, California, 92618, United States
-
Hadassah Medical Center-Hebrew University /ID# 276800
RECRUITINGJerusalem, 91120, Israel
-
Kansai Medical University Hospital /ID# 276586
RECRUITINGHirakata-shi, Osaka, 573-1191, Japan
-
National Cancer Center Hospital East /ID# 276585
RECRUITINGKashiwa-shi, Chiba, 277-8577, Japan
-
Next Oncology - Irving /ID# 276659
RECRUITINGIrving, Texas, 75039, United States
-
Princess Margaret Cancer Centre /ID# 276852
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Rambam Health Care Campus- Haifa /ID# 276799
RECRUITINGHaifa, 3109601, Israel
-
START Midwest /ID# 272505
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
The Chaim Sheba Medical Center /ID# 276798
RECRUITINGRamat Gan, Tel Aviv, 5265601, Israel
-
University of Chicago Medical Center /ID# 276638
RECRUITINGChicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.